Ján Gurský

Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4

Zdeněk Škrott, Martin Mistrík, Klaus Kaae Andersen et al. · Nature · 2017 · 759 citations

Drug Target, Drug Targeting, Medicine +6

Disulfiram’s anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase

Zdeněk Škrott, Dušana Majera, Ján Gurský et al. · Oncogene · 2019 · 114 citations

Medicinal Chemistry, Aldehyde Dehydrogenase, Biochemistry +9

Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells

Svetlana Skolekova, Miroslava Matúšková, Martin Boháč et al. · Cell Communication and Signaling · 2016 · 78 citations · Full text

Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stress

Katarína Chromá, Martin Mistrík, Pavel Moudrý et al. · Oncogene · 2016 · 53 citations

Genome Instability, Rnf168 Show, Dna Damage +8

Imaging flow cytometry as a sensitive tool to detect low‐dose‐induced <scp>DNA</scp> damage by analyzing 53<scp>BP</scp>1 and γ<scp>H2AX</scp> foci in human lymphocytes

Matúš Durdík, Pavol Košík, Ján Gurský et al. · Cytometry Part A · 2015 · 50 citations